The formulation and application of clinical pathways is a process of dynamic improvement and development. The principles of clinical pathways formulation come from multiple disciplines and are constantly enriched and polished in the clinical application of pathways. However, the methodological procedures and reporting standards for the clinical pathway formulation have not been unified internationally. In this paper, we systematically searched and screened the literature on the formulation of clinical pathways, finally determined the methodological literature on the whole process of clinical pathway formulation and comb through the development process in the 5 complete reports. Meanwhile, based on the analysis of the rest of the literature, the suggestions for the clinical pathway formulation process were put forward and discussed to provide reference for hospital managers to develop clinical pathways.

1.De Bleser L, Depreitere R, Waele KD, et al. Defining pathways[J]. Journal of nursing management, 2006, 14(7):  553-563. DOI: 10.1111/j.1365-2934.2006.00702.x.

2.潘哲毅, 徐利民, 陈国军. 论临床路径理论、实施及其意义 [J]. 医院管理论坛, 2013, 30(1): 29-32. [Pan ZY, Xu LM, Chen GJ. Theories, application and significance of clinical pathway[J]. Hospital Management Forum, 2013, 30(1): 29-32.] DOI: 10.3969/j.issn.1671-9069. 2013.01.011.

3.吴袁剑云, 英立平. 临床路径实施手册[M]. 北京：北京医科大学出版社, 2002. [Wu YJY, Ying LP. Manual of clinical pathway implementation[M]. Beijing: The Peking University Health Science Center Press, 2002.]

4.刘晶星. 基于临床路径的天津总医院单病种费用控制的系统研究 [D]. 天津: 天津大学, 2013. [Liu JX. The study on utilization of clinical pathways in controlling the medical expenditure of single disease in Tianjin medical university general hospital[D]. Tianjin: Tianjin University, 2013.] DOI: 10.7666/d.D440978.

5.蔡娟娟. 临床路径在IgA肾病患者管理中的应用探讨  [D]. 石河子:  石河子大学, 2016. [Cai JJ. Application of clinical pathway in the management of patients with IgA nephropathy[D]. Shihezi: Shihezi University, 2016.] DOI: 10.7666/d.D01086304.

6.刘巍. 三问临床路径专家对话还原临床路径真相  [J]. 中国医院院长, 2009, (24): 40-44. [Liu W. Three dialogues with clinical pathway experts to restore the truth of clinical pathway[J]. China Hospital CEO, 2009, (24): 40-44.] DOI: CNKI:SUN:YYYZ.0.2009-24-012.

7.周海龙, 封卫征, 朱晓玲, 等. 某医院临床路径实施情况和影响因素 [J]. 上海预防医学, 2016, 28(7): 505-507. [Zhou HL, Feng WZ, Zhu XL, et al. Implementation and influencing factors of clinical pathways in a hospital[J]. Shanghai Journal of Preventive Medicine, 2016, 28(7): 505-507.] DOI: 10.19428/j.cnki.sjpm.2016.07.021.

8.焦莎莎, 李兴洲, 李少武. PDCA循环应用于临床路径管理的实践 [J]. 中国卫生质量管理, 2013, 20(1): 36-39. [Jiao SS, Li XZ, Li SW. Application of PDCA cycle on clinical pathway management[J]. Chinese Health Quality Management, 2013, 20(1): 36-39.] DOI: 10.13912/j.cnki.chqm.2013.01.009.

9.吕轶娟. 基于卫生经济学理论的医院平均住院日影响因素研究 [J]. 现代医院, 2018, 18(5): 658-661, 665.[Lyu YJ. Research on influencing factors of hospital average length of stay based on health economics[J]. Modern Hospitals, 2018, 18(5): 658-661, 665.] DOI: 10.3969/j.issn.1671-332X.2018.05.011.

10.杨天桂, 刘芳, 黄勇. 临床路径(Clinical pathways)——一种单病种质量管理的现代新模式 [J]. 中国卫生事业管理, 2002, (8): 498-499. [Yang TG, Liu F, Huang Y. Clinical pathways: a new modern model of quality management for single disease[J]. Chinese Health Service Management, 2002, (8): 498-499.] DOI: 10.3969/j.issn.1004-4663.2002.08.023.

11.Gordon M. Steps to pathway development[J]. J Burn Care Rehabil, 1995, 16(2): 197-202. DOI: 10.1097/00004630-199503001-00005.

12.Vanhaecht K, Van gerven E, Deneckere S, et al. The 7-phase method to design, implement and evaluate care pathways[J]. International Journal of Person Centered Medicine, 2012, 2(3): 341-51. DOI: 10.5750/IJPCM.V2I3.247.

13.AACPDM Office. Guidelines for developing an AACPDM care pathway[EB/OL]. (2017) [2023-08-15]. https://www.aacpdm.org/UserFiles/file/CarePathwaysGuidelineDevelopmentNov2017.pdf.

14.Flores EJ, Mull NK, Lavenberg JG, et al. Using a 10-step framework to support the implementation of an evidence-based clinical pathways programme[J]. BMJ Qual Saf, 2019, 28(6): 476-485. DOI: 10.1136/bmjqs-2018-008454.

15.王思成. 基于循证的中医临床路径研制方法研究 [D]. 北京: 北京中医药大学, 2010. [Wang SC. Methodological study on developing guidelines and strategies for clinical pathway of evidence-based Chinese medicine[D]. Beijing: Beijing University of Chinese Medicine, 2010.] https://kns.cnki.net/kcms2/article/abstract?v=5DzVwdTmeh8Bfe6Ac_U-TEBJj-puhVeC6-cgvVRGfM2Q2DXaA_-AE2w61z46t2Hwe_f3Cq4lH_ZoEbKdGY_iFe_mlJ0qFosCcXKtTQ2-jyQG0YdVvlZAGlKiDLSbY0NX&uniplatform=NZKPT&flag=copy.

16.中华人民共和国国家卫生和计划生育委员会. 医疗机构临床路径管理指导原则 [J]. 中国实用乡村医生杂志, 2017, 24(10): 1-3. [National Health and Family Planning Commission. Guiding principles for the management of clinical pathways in medical institutions[J]. Chinese Practical Journal of Rural Doctor, 2017, 24(10): 1-3.] DOI: 10.3969/j.issn.1672-7185.2017.10.002.

17.王梅新,王理瑛,颜萍,等. 新疆包虫病专科培训体系与临床护理路径的研究与应用[Z]. 新疆维吾尔自治区: 新疆医科大学第一附属医院, 2014.

18.Lodewijckx C, Decramer M, Sermeus W, et al. Eight-step method to build the clinical content of an evidence-based care pathway: the case for COPD exacerbation[J]. Trials, 2012, 13: 229. DOI: 10.1186/1745-6215-13-229.

19.Mcgeoch G, Anderson I, Gibson J, et al. Consensus pathways: evidence into practice[J]. N Z Med J, 2015, 128(1408): 86-96. https://pubmed.ncbi.nlm.nih.gov/25662382/.

20.Smith E, Ross FM. Service user involvement and integrated care pathways[J]. Int J Health Care Qual Assur, 2007, 20(2-3): 195-214. DOI: 10.1108/09526860710743345.

21.Talarico R, Cannizzo S, Lorenzoni V, et al. RarERN path: a methodology towards the optimisation of patients' care pathways in rare and complex diseases developed within the European reference networks[J]. Orphanet J Rare Dis, 2020, 15(1): 347. DOI: 10.1186/S13023-020-01631-1.

22.冯云霞, 张千竹, 宋波. 临床路径设计及优化的技术研究 [J]. 中国医院管理, 2018, 38(12): 69-71.[Feng YX, Zhang QZ, Song B. Design and optimization technology research on clinical pathway[J]. Chinese Hospital Management, 2018, 38(12): 69-71.] DOI: CNKI:SUN:YYGL.0.2018-12-030.

23.曾宪涛, 冯佳佳, 蔡广研, 等. 制定/修订《临床路径释义》的基本方法与程序(2020年更新版) [J]. 中国研究型医院, 2020, 7(2): 65-68. [Zeng XT, Feng JJ, Cai GY, et al. The methods and procedures of formulating and revising the interpretation of clinical pathway (2020 update)[J]. Journal of Chinese Research Hospitals, 2020, 7(2): 65-68.] DOI: 10.19450/j.cnki.jcrh.2020.02.014.

24.Hassan IS. Knowledge translation through clinical pathways: principles for practical development and successful use[J]. Saudi J Kidney Dis Transpl, 2013, 24(2): 351-363. DOI: 10.4103/1319-2442.109603.

25.沈洁, 姜安丽. 临床路径研究与实践现状分析及启示 [J]. 护理管理杂志, 2011, 11(7): 493-495. [Shen J, Jiang AL. Current situation of research and practice of clinical pathway and its implication[J]. Journal of Nursing Administration, 2011, 11(7): 493-495.] DOI: 10.3969/j.issn.1671-315X.2011.07.016.

26.吴昕霞, 庄昱, 董书, 等. 临床路径管理本土化改进的策略与实践[J]. 中国医院管理, 2019, 39(10): 34-35. [Wu XX, Zhuang Y, Dong S, et al. Strategy and practice for clinical pathway localization improvement[J]. Chinese Hospital Management, 2019, 39(10): 34-35.] DOI: CNKI:SUN:YYGL.0.2019-10-015.

27.吴建, 王垠莹, 吴翠萍, 等. 中医分组临床路径的本地化开发 [J]. 河南医学研究, 2020, 29(10): 1733-1736. [Wu J, Wang YY, Wu CP, et al. Localization and formulation of TCM-grouping clinical pathway[J]. Henan Medical Research, 2020, 29(10): 1733-1736.] DOI: CNKI:SUN:HNYX.0.2020-10-002.

28.郭君伟, 师新宇. 临床路径变异内涵及分析方法探讨  [J]. 中国研究型医院, 2019, (2): 67-72.[Guo JW, Shi XY. The connotation and analysis methods of clinical pathways variation[J]. Journal of Chinese Research Hospitals, 2019, (2): 67-72.] DOI: 10.19450/j.cnki.jcrh. 2019.02.013.

29.燕辉. 基于过程挖掘的临床路径变异检测研究[D].杭州: 浙江大学, 2019. [Yan H. Detecting deviations in clinical pathways using process mining[D]. Hangzhou: Zhejiang University, 2019.] DOI: 10.27461/d.cnki.gzjdx. 2019.001030.

30.尹璇. 基于医嘱系统的临床路径变异的原因分析及对策 [J]. 江苏卫生事业管理, 2020, 31(3): 306-309. [Yin X. Analysis on the causes of variation of clinical pathway system with medical order as the core and countermeasures[J]. Jiangsu Health System Management, 2020, 31(3): 306-309.] DOI: 10.3969/j.issn.1005-7803.2020.03.010.

31.金旎, 郭佳奕, 何国斌, 等. 基于信息化的临床路径变异分析与对策研究[J]. 医院管理论坛, 2022, 39(9): 37-40. [Jin N, Guo JY, He GB, et al. Study on clinical pathway variation based on information technology and its countermeasures[J]. Hospital Management Forum, 2022, 39(9): 37-40.] DOI: 10.3969/j.issn.1671-9069.2022.09.011.

32.武广华, 班博, 马玲. 医院质控部门在临床路径管理中的作用分析 [J]. 中华医院管理杂志, 2010, 26(7): 502-504. [Wu GH, Ban B, Ma L. Analysis of the role of hospital quality control department in clinical pathway management[J]. Chinese Journal of Hospital Administration, 2010, 26(7): 502-504.] DOI: 10.3760/cma.j.issn.1000-6672.2010.07.009.

33.黄迪. 临床路径报告量表的制定 [D].兰州:  兰州大学, 2016. [Huang D. Development of the reporting checklist for clinical pathway[D]. Lanzhou: Lanzhou University, 2016.] DOI: 10.7666/d.D01034175.

34.黄迪, 崔琦, 宋旭萍, 等. 临床路径报告条目分析与比较[J]. 中国全科医学, 2015, 18(33): 4096-4099. [Huang D, Cui Q, Song XP, et al. Analysis and comparison of clinical pathway report items[J]. Chinese General Practice, 2015, 18(33): 4096-4099.] DOI: 10.3969/j.issn.1007- 9572.2015.33.016.

35.Hassan IS. Knowledge translation through clinical pathways: principles for practical development and successful use[J]. Saudi Journal of Kidney Diseases and Transplantation, 2013, 24(2): 351. DOI: 10.4103/1319-2442.109603.

36.Mallock NA, Braithwaite J. A template for clinical pathway design based on international evidence[J]. Clinical Governance Bulletin, 2005, 5(5): 2.

37.Croucher M. An evaluation of the quality of integrated care pathway development in the UK National Health Service[J]. Journal of Integrated Care Pathways, 2005, 9(1): 6-12.DOI: 10.1177/147322970500900102.

38.戴靖华, 刘沫. 临床路径制定过程中应用循证医学探讨 [J]. 医学与哲学, 2010, 31(24): 3-5, 15. [Dai JH, Liu M. Investigation on evidence-based medicine in course of clinical pathway making[J]. Medicine and Philosophy, 2010, 31(24): 3-5, 15.] DOI: CNKI:SUN:YXZL.0.2010-12-002.

39.朱峰, 李大川, 张文宝, 等. 我国临床路径管理工作回顾与展望 [J]. 中华医院管理杂志, 2018, 34(4): 284-287.[Zhu F, Li DC, Zhang WB, et al. Retrospect and prospect of clinical pathway management in China[J]. Chinese Journal of Hospital Administration, 2018, 34(4): 284-287.]DOI: 10.3760/cma.j.issn.1000-6672.2018.04.005.